News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Chrontech Pharma AB Receives a Six Months’ Extension of Its Option to Buy Back in ChronSeal(R)


5/12/2010 9:30:38 AM

STOCKHOLM--(BUSINESS WIRE)--As a consequence of that the results of the ChronSeal® study will not be made public until May 27th Kringle Inc. in Japan has given ChronTech Pharma (STO:CTEC) a six months’ extension, i.e. until the 31st of December 2010, of its option to buy back in ownership of the ChronSeal®.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES